ALX Oncology
ALXO
ALXO
97 hedge funds and large institutions have $273M invested in ALX Oncology in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2.23% less ownership
Funds ownership: 90.56% → 88.33% (-2.2%)
56% less capital invested
Capital invested by funds: $622M → $273M (-$349M)
Holders
97
Holding in Top 10
3
Calls
$1.31M
Puts
$8K
Top Buyers
| 1 | +$3.46M | |
| 2 | +$3.26M | |
| 3 | +$3.2M | |
| 4 |
BlackRock
New York
|
+$2.48M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$1.51M |
Top Sellers
| 1 | -$14.4M | |
| 2 | -$13.6M | |
| 3 | -$10.9M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$2.85M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.84M |